Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial-Reference-Cited by-同舟云学术

Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial

Published:2017-02-17 Issue:4 Volume:19 Page:509-516
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Petrie John R.¹,Chaturvedi Nish²,Ford Ian¹,Hramiak Irene³,Hughes Alun D.¹,Jenkins Alicia J.⁴,E. Klein Barbara⁵,Klein Ron⁵,Ooi Teik Chye⁶,Rossing Peter⁷,Sattar Naveed¹,Stehouwer Coen D. A.⁸,Colhoun Helen M.⁹,

Affiliation:

1. Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK

2. Institute of Cardiovascular Science; University College London; London UK

3. St Joseph's Health Care; London Ontario Canada

4. NHMRC Clinical Trials Centre; University of Sydney; Australia

5. Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health; Madison Wisconsin

6. Ottawa Hospital Research Institute; The Ottawa Hospital; Ottawa Canada

7. Steno Diabetes Center and the University of Copenhagen; Copenhagen Denmark

8. Department of Internal Medicine and Cardiovascular Research Institute Maastricht (CARIM); Maastricht University Medical Centre; Maastricht The Netherlands

9. Institute of Genetics and Molecular Medicine; University of Edinburgh; UK

Funder

Juvenile Diabetes Research Foundation

Itamar Medical

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12840/fullpdf

Reference49 articles.

1. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study;Livingstone;PLoS Med,2012